This five-year competitive resubmission application requests four predoctoral positions and two postdoctoral positions to continue our """"""""Pharmacology of Drug Abuse"""""""" Training Program. The objective of the training program is to train scientists for careers as independent investigators in the field of drug abuse research. This training program was initiated in 1985. The 13 program faculty members represent several departments, including Biochemistry and Biophysics, Environmental Medicine, Neurobiology and Anatomy, Neurology, and Pharmacology and Physiology. The research activities of the program faculty represent five training areas: AIDS Pharmacology and Drugs of Abuse, Behavioral Pharmacology, Biochemical Pharmacology, Molecular Pharmacology, and Clinical Pharmacology. During the past five years, we have strengthened our training related to AIDS, particularly NeuroAIDS, and HIV-1 replication. The training program recruited Dr. Robert Bambara, Professor of Biochemistry, and an international expert on HIV-1 replication to be part of this training program. Drs. Harris Gelbard and Stephen Dewhurst are experts in NeuroAIDS and in novel approaches toward preventing HIV-1 replication in immunocytes. Our trainees are being exposed to and are participating in AIDS-related research. Predoctoral trainees are recruited from the pool of first-year students in the interdisciplinary Graduate Education in Biomedical Sciences program. Trainees do not select a major subject until the end of their first year of study;hence, all eligible first-year students are potential candidates for support. The training program includes course work, original laboratory research, and participation in Drug Abuse Seminar Series and Colloquium. Predoctoral trainees are required to complete the requirements for the Ph.D. degree in their major department or program and to satisfy the curricular requirements of the training program. Postdoctoral fellows are recruited by individual faculty members, by our web site, and by the use of NIDA's web site. Enrichment activities in addition to the Seminar Series include the Pharmacological Sciences Day, which includes guest speakers and poster presentations. Trainees present research findings at national scientific meetings. This Training Program has served and will continue to serve as the focus for the training and research activities in drug abuse within the University and surrounding community.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Institutional National Research Service Award (T32)
Project #
5T32DA007232-23
Application #
7663761
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Babecki, Beth
Project Start
1985-08-01
Project End
2012-06-30
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
23
Fiscal Year
2009
Total Cost
$245,692
Indirect Cost
Name
University of Rochester
Department
Pharmacology
Type
Schools of Dentistry
DUNS #
041294109
City
Rochester
State
NY
Country
United States
Zip Code
14627
Sarangi, Pranita P; Lee, Hyun-Wook; Lerman, Yelena V et al. (2017) Activated Protein C Attenuates Severe Inflammation by Targeting VLA-3high Neutrophil Subpopulation in Mice. J Immunol 199:2930-2936
Lerman, Yelena V; Kim, Minsoo (2015) Neutrophil migration under normal and sepsis conditions. Cardiovasc Hematol Disord Drug Targets 15:19-28
Boschi, N M; Takeuchi, K; Sterling, C et al. (2015) Differential expression of polycytosine-binding protein isoforms in adrenal gland, locus coeruleus and midbrain. Neuroscience 286:1-12
Gunn, Alana J; Canada, Kelli E (2015) Intra-group Stigma: Examining Peer Relationships Among Women in Recovery for Addictions. Drugs (Abingdon Engl) 22:281-292
Lerman, Yelena V; Lim, Kihong; Hyun, Young-Min et al. (2014) Sepsis lethality via exacerbated tissue infiltration and TLR-induced cytokine production by neutrophils is integrin ?3?1-dependent. Blood 124:3515-23
Chan, Puiyee; Thomas, Celestine J; Sprang, Stephen R et al. (2013) Molecular chaperoning function of Ric-8 is to fold nascent heterotrimeric G protein ? subunits. Proc Natl Acad Sci U S A 110:3794-9
Easterhoff, David; Ontiveros, Fernando; Brooks, Lauren R et al. (2013) Semen-derived enhancer of viral infection (SEVI) binds bacteria, enhances bacterial phagocytosis by macrophages, and can protect against vaginal infection by a sexually transmitted bacterial pathogen. Antimicrob Agents Chemother 57:2443-50
Mock, David J; Hollenbaugh, Joseph A; Daddacha, Waaqo et al. (2012) Leishmania induces survival, proliferation and elevated cellular dNTP levels in human monocytes promoting acceleration of HIV co-infection. PLoS Pathog 8:e1002635
Olsen, Joanna S; DiMaio, John T M; Doran, Todd M et al. (2012) Seminal plasma accelerates semen-derived enhancer of viral infection (SEVI) fibril formation by the prostatic acid phosphatase (PAP248-286) peptide. J Biol Chem 287:11842-9
Silva, Jharon; Polesskaya, Oksana; Knight, Walter et al. (2012) Transient hypercapnia reveals an underlying cerebrovascular pathology in a murine model for HIV-1 associated neuroinflammation: role of NO-cGMP signaling and normalization by inhibition of cyclic nucleotide phosphodiesterase-5. J Neuroinflammation 9:253

Showing the most recent 10 out of 72 publications